The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tysabri     Quarter: 2016Q3

Total Drug/Injury Combinations: 1,135     Number of Pages: 57

DRUGNAME PT EventCount
TYSABRI Jugular vein thrombosis 2 view events
TYSABRI Large intestine perforation 2 view events
TYSABRI Latent tuberculosis 2 view events
TYSABRI Leiomyosarcoma 2 view events
TYSABRI Life support 2 view events
TYSABRI Ligament disorder 2 view events
TYSABRI Light chain disease 2 view events
TYSABRI Lip blister 2 view events
TYSABRI Lung carcinoma cell type unspecified stage IV 2 view events
TYSABRI Lung infection 2 view events
TYSABRI Lymph node pain 2 view events
TYSABRI Lymphadenopathy 2 view events
TYSABRI Lymphocyte count decreased 2 view events
TYSABRI Lymphocytosis 2 view events
TYSABRI Malnutrition 2 view events
TYSABRI Mass 2 view events
TYSABRI Mastectomy 2 view events
TYSABRI Mastitis 2 view events
TYSABRI Meconium aspiration syndrome 2 view events
TYSABRI Melanocytic naevus 2 view events

Total Drug/Injury Combinations: 1,135     Number of Pages: 57

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)